These are the days of the empowered patient — the patient who asks questions, who wants to know about how to prevent the diseases that ailed their parents or how to live more successfully with the conditions they have, who seeks and finds health information from doctors, nurses, magazines and most especially from the teeming trove of online health sites.
Three bills that were introduced in California would recognize pharmacists as healthcare providers and would enable pharmacists, nurse practitioners and optometrists to practice to the full extent of their education and training.
The reality is that industry observers can expect to see more states considering similar measures as they all prepare a roadmap to lower costs by allowing pharmacists and NPs to practice at the top of their professions.
A decade ago, the Journal of the American Pharmacists Association published a study that examined the state of collaborative practice. In 2003, 32 states had pharmacist collaborative practice regulations. Of those, 23 states allowed pharmacists to initiate and modify drug therapy.
Pharmacies using McKesson EnterpriseRx pharmacy-management system can send patients information about health clinics, drug recalls, coupons and real-time surveys through their mobile phones using an integrated mobile communication system.
With the prevalence of chronic disease conditions on the rise, Great-West Life, a provider of drug plan management solutions, and Canadian pharmacy retailer Shoppers Drug Mart have entered into an agreement to introduce two new health support programs for Great-West Life clients.
The National Community Pharmacists Association called for the rejection of a proposal made by Sens. Joe Manchin, D-W.Va., and Mark Kirk, R.-Ill., to reschedule Vicodin and other hydrocodone-containing products from Schedule III to Schedule II of the Controlled Substances Act.
It’s often the case that those in the midst of revolutionary times don’t really see how fundamentally the world around them is changing until long after the changes have occurred. So let’s start by declaring that the revolution has begun: Genomic research will dramatically transform both the practice of pharmacy and the way patients are treated with medications for many diseases.
The sequencing of the human genome was a huge scientific breakthrough, and it’s spawning additional breakthroughs as genetic testing labs spring up and the cost of testing individual patients for their ability to metabolize a particular drug drops to affordable levels for health plan payers.
Kentucky became the first state to enact legislation that provides pharmacists with transparency into how health plans determine pharmacy reimbursements for generic drugs, and establishes an appeals process when a dispute arises over those payment levels.
In collaboration with Walgreens, the University of Nebraska Medical Center unveiled a new treatment model to help positively impact clinical outcomes for hypertension and Type 2 diabetes patients through a program made possible by a National Association of Chain Drug Stores Foundation grant.
On Thursday morning, Walgreens opened the doors to its latest flagship location in the nation's capital, bringing to District of Columbia residents and commuters the kind of retail pharmacy theater already familiar with citizens of New York, Chicago and Los Angeles.
Hamacher Resource Group is offering pharmacists a new service that it said would allow them to get the top prescriptions dispensed in their two-digit ZIP code to ensure they are accurately and competitively pricing drugs.
One major theme resonating across the show floor at HIMSS13 was the importance of interoperability within healthcare ecosystems. Emdeon's Lathe Bigler discusses how interoperability in the pharmacy space has been centered on advances in e-prescribing and clinical messaging.
Last week, I wrote about Medication Therapy Management and a new bill in the House of Representatives to expand the pool of patients who qualify for MTM programs through Medicare. This week, I’m writing about – wait for it – medication therapy management.
Why? Because MTM is important, vitally important, to the future of community pharmacy, and one of the key health and prevention services that will define the profession in the era of health reform and evidence-based health care.
The National Association of Chain Drug Stores applauded the introduction of S. 557, the Medication Therapy Management Empowerment Act of 2013, introduced yesterday by U.S. Sens. Kay Hagan, D-N.C., and Pat Roberts, R-Kan., along with the support of original cosponsors U.S. Sens. Sherrod Brown, D-Ohio, Al Franken, D-Minn., Tim Johnson, D-S.D., and Amy Klobuchar, D-Minn.